-transparent.png){kind=logo}
The efficacy of piperacillin/tazobactam (PIPC/TBT) in combination with gentamicin was assessed as empirical therapy in 44 febrile neutropenic patients with haematological malignancy. A favourable response to therapy was seen in 67% patients overall and in 57% of patients with microbiologically documented infection. PIPC/TBT demonstrated good clinical and in vitro activity against isolated pathogens, particularly Gram positive cocci such as Staphylococcus epidermidis. The MIC of both Gram positive and Gram negative pathogens to PIPC was reduced in the presence of TBT. PIPC/TBT plus gentamicin is a safe and effective combination for empirical therapy in febrile neutropenic patients, even in a unit with a predominance of Gram positive infections.
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
August 1997,
Journal of chemotherapy (Florence, Italy),
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
May 2011,
Pediatric hematology and oncology,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
March 1985,
The Journal of antimicrobial chemotherapy,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
May 2005,
Current medical research and opinion,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
July 2002,
Annals of internal medicine,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
April 2009,
Journal of pediatric hematology/oncology,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
January 2008,
Singapore medical journal,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
June 2003,
Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
February 2015,
World journal of oncology,
S M Kelsey, and
B Weinhardt, and
C E Pocock, and
E Shaw, and
A C Newland
July 1998,
European journal of medical research,
